The purpose of this study is to compare pain scores, WOMAC total and subscores, actual and change of joint space width and the rate of gastrointestinal side effects at 4, 8, 12, and 24 weeks between dual-therapy of diacerein and glucosamine versus a mono-therapy of glucosamine in OA patients
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
148
Sugar pill manufactured to mimic Diacerein 50 mg tablet
Department of Orthopaedics, Faculty of Medicine Ramathibodi Hospital, Bangkok, Mahidol University
Bangkok, Thailand
pain visual analog scores
Time frame: 24 weeks
Western Ontario and McMaster Universities Osteoarthritis (WOMAC) scores
Time frame: 24 weeks
actual and change of joint space width
Time frame: 24 weeks
Rate of gastrointestinal side effects
Time frame: 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.